$ASPN

Aspen Aerogels Q2 Earnings Call Highlights

Aspen Aerogels (ASPN) reported Q2 gross profit of $3.3M (7% margin) after $5.3M of incremental costs tied to an April explosion at its East Providence plant. Adjusted gross profit was $8.6M (17%). GAAP net loss was $23.3M. The company is restarting the plant and expects full capacity in 1H 2027, while raising 2026 European Thermal Barrier revenue outlook to $20M-$30M.

Original reporting
Published Aug 9, 2026, 7:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 7:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aspen Aerogels Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ASPNBullishMed
01

Why it matters

Traders can update models for (1) European Thermal Barrier revenue trajectory via the raised 2026 range and Jaguar Land Rover award, and (2) near-term earnings drag via quantified incident-related charges and continued restart costs into 2027.

02

Market read

The combination of a European guidance raise, a new major OEM selection, and explicit incident-cost and restart timing provides actionable updates for ASPN’s near-term margin/cash outlook and 2026-2027 revenue ramp assumptions.

03

What to watch

Incident-related expenses are expected to continue until full capacity, and the company’s cash balance declined sequentially, which could constrain risk appetite despite guidance improvements.

Relevance 7/10Novelty 6/10Timing: Q2 earnings call highlights, pre-market today

Background

Aspen Aerogels discussed Q2 results and the ongoing restart of its East Providence aerogel plant after an April explosion, alongside updated revenue outlooks for European thermal barriers and growth plans for Energy Industrial and battery storage.

Company-level read

Ticker impact

$ASPNBullishMedium confidence
Context

Aspen Aerogels raised its 2026 European Thermal Barrier revenue outlook to $20M-$30M and detailed incident-related costs and plant restart timing.

Expected impact

Near-term bias upward on guidance and customer award news, with volatility around incident cost guidance and cash balance.

Evidence & confidence

The article provides specific, decision-relevant updates: raised 2026 revenue range, Jaguar Land Rover customer selection, and quantified incident-related charges ($5M-$10M in Q3) alongside a staged restart targeting full capacity in 1H 2027.

Market effects

Improves read-through for aerogel insulation demand in European OEM thermal barrier programs and highlights execution risk tied to manufacturing incidents.

European OEM revenue outlook upgrade may strengthen regional sentiment for insulation suppliers tied to vehicle thermal management.

LNG and subsea activity growth commentary supports broader industrial insulation demand expectations beyond autos.

Counterpoint

The raised European outlook may not fully offset the margin and cash pressure from the East Providence incident, with full capacity not expected until 1H 2027.

Key entities

  • Aspen Aerogels

    Discussed Q2 financials, plant restart timeline, raised European Thermal Barrier outlook, and growth plans for Energy Industrial and BESS.

  • East Providence manufacturing facility

    Restart underway after an April explosion; full production capacity expected in 1H 2027.

  • Jaguar Land Rover

    Selected PyroThin thermal barriers for multiple vehicle architectures, expanding Aspen’s European OEM customer base.

Related articles

$ASPNMed

Beerenberg Prevails in Patent Case Against Aspen Aerogels

South Korea’s Patent Court invalidated three Aspen Aerogels patents covering improved hydrophobic aerogel material, according to the company’s press release. The ruling upheld the Intellectual Property Trial and Appeal Board’s view that the patents failed patentability requirements. Beerenberg, an insulation-products firm, said the decision removes uncertainty over infringement claims.

$DCOMed

Ducommun Q2 Earnings Call Highlights

Ducommun (NYSE:DCO) reported Q2 adjusted EBITDA of $38.4M (17.1% of revenue) versus $31.7M a year earlier. GAAP net income rose to $20.4M ($1.31/share). Defense revenue was $124M, up to missile growth, and remaining performance obligations hit a record $1.16B. Commercial aerospace revenue rose to $89M. CFO cited a one-time compensation clawback.

$DCHMedAI 8/10

American Axle & Manufacturing Q2 Earnings Call Highlights

American Axle & Manufacturing (DCH) reported Q2 adjusted EBITDA of $389.6M (13.2% of sales). It recorded $15M in quarterly synergy benefits and targets $100M+ by year-end. Cash from operations was $107.5M and adjusted free cash flow $148.4M. Full-year guidance raised: sales $10.6B-$10.8B and adjusted EBITDA $1.36B-$1.425B.

$DHTMed

DHT Q2 Earnings Call Highlights

DHT Holdings reported Q2 liquidity of $569 million, including $161.7 million cash and $407.5 million under revolving credit facilities. Company said operations generated $231 million EBITDA. It repaid $20 million debt and interest, paid $103 million dividends, and pre-paid $56 million long-term debt. DHT fixed charters and ordered a new VLCC, plus updated Q3 day-rate expectations.

$DKMed

Delek US Q2 Earnings Call Highlights

Delek US (NYSE: DK) Q2 earnings call covered refining margins, throughput guidance, and cash flow. Management said refined-product markets may take several quarters to normalize and that a less backwardated forward curve could lift realized crack spreads. Q3 throughput guided to 296,000-316,000 bpd, with Opex $220-$230M and D&A $110-$120M. Delek Logistics Partners reported ~$144M adjusted EBITDA and reaffirmed 2026 guidance of $520-$560M.